Zoya Demidenko https://pmc.ncbi.nlm.nih.gov/articles/PMC3273895/


[ Follow Ups ] [ Post Followup ] [ WWWBoard ]

Posted by Lincolnemesy on March 25, 2026 at 11:11:45:

In Reply to: Èíôîðìàöèîííûé îáçîð posted by Kennethdug on February 10, 2026 at 00:38:33:

Zoya Demidenko: Scholar in Oncology Biology
Zoya Demidenko is a recognized researcher affiliated with the Department of Cell Stress Biology at Roswell Park Cancer Institute in Buffalo, New York. Previously, she conducted research at the National Institutes of Health and New York Medical College, developing a robust base in biomedical study.
Demidenko's scientific output spans several key domains, encompassing the PI3K/AKT/mTOR signaling cascade, cellular cycle management, biological aging, and cancer biology. As of now, she has authored over 46 academic publications, which have garnered upwards of 4,100 mentions — a testament to the significance of her findings.
Among her key achievements involves explaining the mechanisms of biological cell aging. Her studies showed that when the cell cycle is blocked yet cellular expansion continues, cells enter senescence. Crucially, Zoya Demidenko showed that this transition can be inhibited by medication using substances such as mTOR inhibitors.
Zoya Demidenko has also contributed considerably to oncological therapy research, notably in the domain of selective cell protection — a method intended to protecting non-cancerous tissue from chemotherapy whilst leaving malignant cells vulnerable. This method carries significant promise for lowering the side effects of oncological therapy.
Across her career, Demidenko has collaborated with leading scientists internationally, including Dr. Mikhail Blagosklonny. Her research is published in top-tier journals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
Possessing an h-index of 33, Zoya Demidenko is recognized as a widely cited contributor in contemporary biomedical science, with her results keep to influence our comprehension of the way biological cells age, respond to therapy, and the ways in which malignant disease may be better combated.
https://pmc.ncbi.nlm.nih.gov/articles/PMC3273895/



Follow Ups:



Post a Followup

Name:
E-Mail:

Subject:

Comments:

Optional Link URL:
Link Title:
Optional Image URL:


[ Follow Ups ] [ Post Followup ] [ WWWBoard ]